Rousselot® set to inspire at Vitafoods 2022 with new consumer study into its unique collagen matrix for joint care

At this year’s event, Rousselot’s exhibition will reintroduce its all-in-one collagen matrix designed to provide joint care solutions for a wide range of consumer demographics. In addition, the company will spotlight the benefits of porcine collagen ingredients and its SiMoGel™ gelatin solution for innovative nutraceutical gummies.

Booth I114 Vitafoods, Geneva, Switzerland, 10-12 May 2022

Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions⁽¹⁾, invites visitors to booth I114 at Vitafoods 2022 to discover its latest collagen and gelatin ingredient innovations. At this year’s event, Rousselot’s exhibition will reintroduce its all-in-one collagen matrix designed to provide joint care solutions for a wide range of consumer demographics. In addition, the company will spotlight the benefits of porcine collagen ingredients and its SiMoGel™ gelatin solution for innovative nutraceutical gummies.

Visitors to Rousselot’s booth can also make use of the Live Chat Corner, allowing them to connect and discuss with formulation experts and also explore tailored technical solutions for their specific formulation challenges.  

Presenting a new perspective on senior joint care  

In less than 30 years, the number of people aged 60 years and over is expected to double, reaching a total of 2.1 billion⁽²⁾. In parallel to these demographic changes, the market value of dietary supplements aimed at supporting mobility is forecast to grow by 4.7% CAGR by 2026⁽³⁾. The stage is set for a new generation of nutritional solutions, formulated to support bone and joint health and help an aging global population keep fit into later life. On Tuesday 10 May at 2:30pm at the Life Stages Theatre, Dr. Sara De Pelsmaeker, Global Business Development Health & Nutrition at Rousselot will unveil the findings of a wide-ranging new study to help brands address these shifting consumer trends. Through her speech, entitled ‘Joint care innovation with an all-in-one collagen matrix, fueled by new consumer-based science’, attendees will discover the impact of Rousselot’s collagen matrix on the real-world joint care of more than two-hundred people, all varying in age, gender, and activity level.  

Broadening access to science-backed collagen solutions

The company’s flagship collagen brand, Peptan® is a fully bioavailable collagen peptide ingredient which delivers a world of science- backed health benefits, from joint support and bone health, to enhanced skin and hair beauty. At this year’s Vitafoods event, Rousselot will highlight the specific advantages of Peptan P, an accessible premium-quality collagen solution of porcine origin that offers a fast route to market. Event attendees can experience the functional and sensory properties of Peptan P on-stand, through specialized samples, including an oat-based breakfast solution tailored for the nutritional needs of seniors.

Innovative gelatin solutions for center-filled functional gummies

With an attractive appearance, taste and texture that makes them easy to swallow, the appeal of nutritional gummies is easy to understand. Manufacturing this type of delivery format however, can be a difficult task, as traditional starch molding techniques present a risk of active pharmaceutical ingredient (API) cross-contamination. Rousselot’s innovative SiMoGel™ gelatin solution means manufacturers can produce functional, liquid-center filled gummies using an inherently hygienic, starch-free molding technique. These innovative ‘gummy caps’ allow for higher and more accurate API dosing, with virtually no risk of interaction with the gelatin excipient.

SiMoGel’s unique potential can be discovered in person at Rousselot’s booth, where visitors can sample liquid-center gummies with Ibuprofen, along with other inspiring application prototypes for the all-in-one collagen matrix.  

(1) Global Gelatin Market Insights Forecast to 2026, Calibre Research, 2020.

(2) The World Health Organisation, Aging and Health, October 2021

(3) Euromonitor